C07K

Technology

Follow

Stats

Description

PEPTIDES (peptides containing -lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D 519/02; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N 15/00)

Recent Patents

Not Available
Patent #TitleFiling DateIssue DatePatent Owner
8,784,385 Frozen piercing implements and methods for piercing a substrate Sep 15, 09 Jul 22, 14 THE INVENTION SCIENCE FUND I, LLC, THE INVENTION SCIENCE FUND I, LLC
8,784,777 Flexibly labeling peptides Nov 29, 10 Jul 22, 14 CASE WESTERN RESERVE UNIVERSITY, CASE WESTERN RESERVE UNIVERSITY
8,784,809 Vascular endothelial growth factor 2 Jan 24, 13 Jul 22, 14 HUMAN GENOME SCIENCES, INC., HUMAN GENOME SCIENCES, INC.
8,784,811 Method of treating cancer using antibodies to a non-ligand binding region of NOTCH1 Feb 22, 13 Jul 22, 14 ONCOMED PHARMACEUTICALS, INC., ONCOMED PHARMACEUTICALS, INC.
8,784,814 Method for inhibiting binding to B-cell receptor Jun 28, 12 Jul 22, 14 GLAXO GROUP LIMITED, GLAXO GROUP LIMITED
8,784,823 Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind CD154 and uses thereof Oct 22, 12 Jul 22, 14 UCB BIOPHARMA SPRL, BIOGEN IDEC MA INC.; UCB BIOPHARMA SPRL;
8,784,825 Modulators of MYC, methods of using the same, and methods of identifying agents that modulate MYC Aug 28, 09 Jul 22, 14 TAIGA BIOTECHNOLOGIES, INC., TAIGA BIOTECHNOLOGIES, INC.
8,784,828 proteins, nucleic acids, and methods of their use May 05, 08 Jul 22, 14 THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION, THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION
8,784,829 vaccines Oct 21, 09 Jul 22, 14 INTERVET INC., INTERVET INC.
8,784,830 Antigen peptide and use thereof May 23, 11 Jul 22, 14 INTERVET INC., Not available
8,784,833 Prenatal enzyme replacement therapy for hypophosphatasia Jan 17, 11 Jul 22, 14 SAINT LOUIS UNIVERSITY, SAINT LOUIS UNIVERSITY
8,785,135 Mutant G-protein coupled receptors and methods for selecting them Mar 20, 08 Jul 22, 14 HEPTARES THERAPEUTICS LIMITED, HEPTARES THERAPEUTICS LIMITED
8,785,151 Biosynthetically generated pyrroline-carboxy-lysine and site specific protein modifications via chemical derivatization of pyrroline-carboxy-lysine and pyrrolysine residues Oct 23, 09 Jul 22, 14 HEPTARES THERAPEUTICS LIMITED, Not available
8,785,369 Neuregulins for prevention and treatment of damage from acute assault on vascular and neuronal tissue and as regulators of neuronal stem cell migration Jan 26, 09 Jul 22, 14 MOREHOUSE SCHOOL OF MEDICINE, MOREHOUSE SCHOOL OF MEDICINE
8,785,376 Isolation, identification, and uses of antifungal compounds Dec 20, 11 Jul 22, 14 VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY, VIRGINIA TECH INTELLECTUAL PROPERTIES; UNIVERSITY OF UTAH RESEARCH FOUNDATION;
8,785,377 Tetrazolyl macrocyclic hepatitis C serine protease inhibitors Jan 18, 08 Jul 22, 14 ENANTA PHARMACEUTICALS, INC., ENANTA PHARMACEUTICALS, INC.
8,785,385 RTEF-1 variants and uses thereof Apr 19, 11 Jul 22, 14 RESEARCH DEVELOPMENT FOUNDATION, RESEARCH DEVELOPMENT FOUNDATION; OREGON HEALTH & SCIENCE UNIVERSITY;
8,785,388 TAT-BH3 methods for treating arthritis Feb 14, 08 Jul 22, 14 SAINT LOUIS UNIVERSITY, SAINT LOUIS UNIVERSITY
8,785,391 Compound and method for treatment of alzheimer's disease and familial dementia Jun 24, 10 Jul 22, 14 ALPHABETA AB, ALPHABETA AB
8,785,392 Method for inhibiting cancer metastasis by administration of the extracellular domain DLK1 or a DLK1-FC fusion protein Apr 13, 10 Jul 22, 14 KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY, KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY

more results

Recent Publications

Not Available
Publication #TitleFiling DatePub DatePatent Owner
2014/0205,560 MULTIMERIC IL-15 SOLUBLE FUSION MOLECULES AND METHODS OF MAKING AND USING SAME Jul 19, 13 Jul 24, 14 , ALTOR BIOSCIENCE CORPORATION
2014/0205,562 IL-1 BINDING PROTEINS Dec 18, 13 Jul 24, 14 , ABBVIE INC.
2014/0205,568 Promyelocytic Leukemia Protein as a Redox Sensor Mar 07, 14 Jul 24, 14 , INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)
2014/0205,570 RECOMBINANT ADENO-ASSOCIATED VIRUS-MEDIATED EXPRESSION OF FRACTALKINE FOR TREATMENT OF NEUROINFLAMMATORY AND NEURODEGENERATIVE DISEASES Jun 30, 12 Jul 24, 14 , THE UNIVERSITY OF SOUTH FLORIDA
2014/0205,588 PLASMINOGEN AND PLASMIN VARIANTS Aug 13, 12 Jul 24, 14 , THROMBOGENICS NV
2014/0205,593 MONOVALENT ANTIBODY FRAGMENTS USEFUL AS THERAPEUTICS Apr 15, 13 Jul 24, 14 , GENENTECH, INC.
2014/0205,597 TECHNIQUES FOR PREDICTING, DETECTING AND REDUCING ASPECIFIC PROTEIN INTERFERENCE IN ASSAYS INVOLVING IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS Dec 23, 13 Jul 24, 14 , ABLYNX N.V.
2014/0205,598 Methods for Treating Disseminated Intravascular Coagulation by Inhibiting MASP-2 Dependent Complement Activation Jan 30, 14 Jul 24, 14 , UNIVERSITY OF LEICESTER; OMEROS CORPORATION;
2014/0205,599 POLYPEPTIDE THAT BINDS ABERRANT CELLS AND INDUCES APOPTOSIS Dec 22, 11 Jul 24, 14 , Not available
2014/0205,600 METHODS OF PROMOTING FAT LOSS COMPRISING ADMINISTERING AN ALK7 INHIBITOR Jan 24, 14 Jul 24, 14 , ACCELERON PHARMA INC.
2014/0205,601 AMINO ACID SEQUENCES DIRECTED AGAINST RANK-L AND POLYPEPTIDES COMPRISING THE SAME FOR THE TREATMENT OF BONE DISEASES AND DISORDERS Dec 11, 13 Jul 24, 14 , ABLYNX N.V.
2014/0205,602 ANTAGONIST ANTI-CD40 MONOCLONAL ANTIBODIES AND METHODS FOR THEIR USE Dec 19, 13 Jul 24, 14 , NOVARTIS VACCINES AND DIAGNOSTICS INC.
2014/0205,603 SIGLEC-15 ANTIBODIES IN TREATING BONE LOSS-RELATED DISEASE Jan 07, 14 Jul 24, 14 , ALETHIA BIOTHERAPEUTICS INC.
2014/0205,604 ANTIGEN BINDING CONSTRUCTS Jul 25, 12 Jul 24, 14 , GLAXO GROUP LIMITED
2014/0205,605 OPTIMIZED ANTIBODIES THAT TARGET HM1.24 Mar 11, 13 Jul 24, 14 , XENCOR INC.
2014/0205,606 ANTI C-MET ANTIBODIES Dec 06, 13 Jul 24, 14 , ARGEN-X B.V.
2014/0205,607 FOCUSED EVOLUTION OF HIV-1 NEUTRALIZING ANTIBODIES REVEALED BY CRYSTAL STRUCTURES AND DEEP SEQUENCING Mar 23, 12 Jul 24, 14 , DUKE UNIVERSITY; THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH; THE U.S.A. AS REPRESENTED BY THE SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVICES;
2014/0205,608 Use of c-Fms antagonists Jul 17, 12 Jul 24, 14 , MORPHOSYS AG; THE UNIVERSITY OF MELBOURNE;
2014/0205,610 ANTI-FOLR1 ANTIBODY Nov 25, 13 Jul 24, 14 , KYOWA HAKKO KIRIN CO., LTD.
2014/0205,611 MONOCLONAL ANTIBODIES THAT BIND TO HGM-CSF AND MEDICAL COMPOSITIONS COMPRISING SAME Jan 28, 14 Jul 24, 14 , BOEHRINGER INGELHEIM INTERNATIONAL GMBH; EVEC INC.;

more results

Top Owners in This Class

Patents Filed in This Class - By Year

We are sorry but your current selection exceeds the maximum number of follows () for this membership level. Upgrade to our Level for up to follows!

Technology Follow
C07K
CONFIRM CANCEL
UPGRADE MEMBERSHIP CANCEL